The Claim

In heart transplant recipients, treatment with GLP-1 receptor agonists is associated with reduced proton leak in myocardial mitochondria, as evidenced by lower leak respiration and a lower leak control ratio, which may reflect improved mitochondrial membrane integrity.

Source: GLP-1 receptor agonists are associated with higher mitochondrial coupling efficiency in the human heart

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
27score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Heart transplant patients on GLP-1 drugs might have healthier heart cell energy factories because their cells are leaking less energy.

See the scientific wording

In heart transplant recipients, treatment with GLP-1 receptor agonists is associated with reduced proton leak in myocardial mitochondria, as indicated by lower leak respiration (38.09 ± 15.29 vs. 57.94 ± 16.65 pmol O2/s*mg, p = 0.02) and a lower leak control ratio (LCR: 0.39 ± 0.03 vs. 0.54 ± 0.16, p = 0.02), which may reflect improved mitochondrial membrane integrity.

What the research says

1 study

  1. Study: GLP-1 receptor agonists are associated with higher mitochondrial coupling efficiency in the human heart

    The study found that patients on GLP-1 receptor agonists had healthier heart cell energy factories (mitochondria) with less energy leakage, which matches the claim.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.